Trends of Asthma Exacerbation Readmission Rates: A Review of a National Database

Obaidat, Baha; Alkhatib, Ala; Garcia, Michael; Tabba, Maher

doi:10.1016/j.chest.2016.08.942

Cited by 4 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The readmission rate for COPD patients in China is much lower than that of their American counterparts (5.6% versus 7.2%) in the same period from 2009 to 2012 [ 15 ], and this can also be seen in elderly patients (4.7% for Chinese patients aged ≥61 years versus 6.8% for American patients aged ≥65 years) from 2008 to 2012 [ 15 , 32 ]. In contrast to COPD, there has been a significant increment in asthma readmission rates between 2005 and 2015 with an average readmission rate of 6.2%, which is higher than that in the United States [ 33 ], especially between 2009 and 2013 (7.0% versus 5.1%). Pneumonia was a kind of acute disease, thus having the lowest readmission rate.…”

Section: Discussionmentioning

confidence: 99%

Hospitalization Trends in Adult Patients with COPD and Other Respiratory Diseases in Northeast China from 2005 to 2015

Liu

Wang

Chen

et al. 2018

BioMed Research International

View full text Add to dashboard Cite

Chronic obstructive pulmonary disease (COPD), pneumonia, asthma, and lung cancer are four common respiratory diseases that impose a substantial economic burden on both patients and government in China. The objective of our study is to analyze the temporal trends of several clinical tracking metrics for hospitalization regarding these diseases. Hospital discharge data of 54 hospitals for the period 2005–2015 were derived from the Health and Family Planning Commission in Northeast China. The age-adjusted rate of discharge for the four respiratory diseases increased significantly (COPD, pneumonia, asthma: P trend < .001; lung cancer: P trend = .046). The mean LOS for the four diseases all showed a significant decline (P trend < .001), whereas the mean charge per stay and aggregate charge followed an upward trend over time (P trend < .001). There was a clear upward trend for the readmission rate for asthma patients (P trend = .001), while the trend for COPD patients was unclear (P trend = .224). Age-adjusted discharge rates, LOS, and charges for hospitalization regarding several common respiratory diseases in China showed different patterns of change over the past decade. Our results should aid government and administrators in making informed decisions about the management and treatment of respiratory diseases.

show abstract

Section: Discussionmentioning

confidence: 99%

Hospitalization Trends in Adult Patients with COPD and Other Respiratory Diseases in Northeast China from 2005 to 2015

Liu

Wang

Chen

et al. 2018

BioMed Research International

View full text Add to dashboard Cite

show abstract

“…The lack of information on hospital readmissions is also a limiting factor caused by using an anonymous database. This parameter would be a potential indicator of the quality of healthcare provided and an objective of effectiveness and efficiency [52,53].…”

Section: Discussionmentioning

confidence: 99%

Trends in asthma hospitalizations among adults in Spain: Analysis of hospital discharge data from 2011 to 2020

Caballero-Segura

López‐de‐Andrés²,

Jiménez‐García³

et al. 2022

Respiratory Medicine

View full text Add to dashboard Cite

“…From 2009 to 2013, asthma admissions in the USA totaled 1,220,047. The readmission rate within 30 days was more than 5% [ 17 ]. Among children who were hospitalized for asthma, around 20% were readmitted the next year.…”

Section: Discussionmentioning

confidence: 99%

Health Effects of the Asthma Care Program under the Universal Coverage Scheme in Children and Young Adults in Thailand

Inmai

Liabsuetrakul

Ichihara

et al. 2022

IJERPH

View full text Add to dashboard Cite

This study aimed to evaluate the effect of the asthma care program available under the Universal Coverage Scheme (UCS) in Thailand on hospital admissions per 100,000 population, its regional and seasonal variation, readmission within 28 days, and the asthma-specific fatality rate of patients aged 0–29 years in 2009–2016 compared with those in 2007–2008. A retrospective study was conducted using data sources from the UCS register and in-patient databases from the National Health Security Office (NHSO), Thailand. Hospital admissions per 100,000 population was the highest among those aged 0–4 years, but the trends decreased from 470.8 to 288.1 per 100,000 population in 2010–2014. The hospital admission rates were high in Southern Thailand and common in rainy seasons. The readmission rates within 28 days slightly decreased in all age groups in 2016 compared to those in 2007. The case fatality rate of patients aged 20–29 years decreased from 0.40% in 2007 to 0.34% in 2016. The readmission rate within 28 days and case fatality rate were the highest in patients aged 20–29 years. In conclusion, the asthma hospital admission, readmission, and case fatality rates declined over time along with the investment in the asthma care program under the UCS in Thailand. The highest hospital admission rates in patients aged 0–4 years and the readmission and case fatality rates in patients aged 20–29 years should be given more attention. Recordings of individual service utilization data in asthma patients, including quality of care provided, should be monitored to improve the asthma care system.

show abstract

Trends of Asthma Exacerbation Readmission Rates: A Review of a National Database

Cited by 4 publications

References 0 publications

Hospitalization Trends in Adult Patients with COPD and Other Respiratory Diseases in Northeast China from 2005 to 2015

Hospitalization Trends in Adult Patients with COPD and Other Respiratory Diseases in Northeast China from 2005 to 2015

Trends in asthma hospitalizations among adults in Spain: Analysis of hospital discharge data from 2011 to 2020

Health Effects of the Asthma Care Program under the Universal Coverage Scheme in Children and Young Adults in Thailand

Contact Info

Product

Resources

About